Advances in BRAF-targeted therapies for non-small cell lung cancer: the promise of encorafenib and binimetinib

被引：1
作者：
Fareed, Areeba [1 ]
Amir, Nabiha [1 ]
Ajaz, Humna [2 ]
Sohail, Afra [1 ]
Vaid, Rayyan [1 ]
Farhat, Solay [3 ]
机构：
[1] Karachi Med & Dent Coll, Dept Med, Karachi, Pakistan
[2] Jinnah Sindh Med Univ, Karachi, Pakistan
[3] Lebanese Univ, Fac Med Sci, Beirut, Lebanon
来源：
INTERNATIONAL JOURNAL OF SURGERY | 2024年 / 110卷 / 04期
关键词：
OPEN-LABEL; DABRAFENIB;
D O I：
10.1097/JS9.0000000000001051
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1891 / 1893
页数：3
相关论文
共 50 条
  • [41] New advances in immunotherapy for non-small cell lung cancer
    Qin, Haifeng
    Wang, Fang
    Liu, Hui
    Zeng, Zhen
    Wang, Shasha
    Pan, Xin
    Gao, Hongjun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (08): : 2234 - 2245
  • [42] Advances in the Treatment of Non-Small Cell Lung Cancer: Immunotherapy
    Patel, Shetal A.
    Weiss, Jared
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 237 - +
  • [43] Safety of Surgery after Neoadjuvant Targeted Therapies in Non-Small Cell Lung Cancer: A Narrative Review
    Marjanski, Tomasz
    Dziedzic, Robert
    Kowalczyk, Anna
    Rzyman, Witold
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [44] Therapeutic impact of molecular diagnosis in metastatic non-small cell lung cancer: Targeted therapies in 2013
    Pecuchet, N.
    Bigot, F.
    Henni, M.
    Fabre, E.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2014, 70 (1-2) : 38 - 46
  • [45] Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy
    Rodak, Olga
    Peris-Diaz, Manuel David
    Olbromski, Mateusz
    Podhorska-Okolow, Marzenna
    Dziegiel, Piotr
    CANCERS, 2021, 13 (18)
  • [46] Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer
    Hines, Jacobi B.
    Bowar, Benjamin
    Levine, Emma
    Esposito, Alessandra
    Garassino, Marina C.
    Bestvina, Christine M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [47] A pharmacological exploration of targeted drug therapy in non-small cell lung cancer
    Jayan, Ajay P.
    Anandu, K. R.
    Madhu, Krishnadas
    Saiprabha, V. N.
    MEDICAL ONCOLOGY, 2022, 39 (10)
  • [48] Molecularly targeted therapies in non-small cell lung cancer: The evolving role of tyrosine kinase inhibitors
    Doval, D.
    Desai, C.
    Sahoo, T.
    INDIAN JOURNAL OF CANCER, 2019, 56 (05) : 23 - 30
  • [49] Treatment of KRAS-Mutant Non-Small Cell Lung Cancer The End of the Beginning for Targeted Therapies
    Kaufman, Jacob
    Stinchcombe, Thomas E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (18): : 1835 - 1837
  • [50] Encorafenib and Binimetinib: A New Treatment Option for BRAFV600E-Mutant Non-Small-Cell Lung Cancer
    Stinchcombe, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (21) : 3679 - +
12345